Patents by Inventor Marco Rudolf

Marco Rudolf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230200527
    Abstract: The invention provides for an oral treatment unit, or an assembly of a plurality of oral treatment units, for confining an electromagnetic field having a frequency in the range of 100 kHz to 300 MHz and adapted to be inserted into an oral cavity, which may form part of an oral cleaning device in combination with a base unit, including a first cleaning element coupled to the oral treatment unit. The oral treatment unit further includes a material structure coupled to the oral treatment unit adapted to receive an initial electromagnetic field and output a focused electromagnetic field, wherein the material structure has a passive electromagnetic field focusing function, which focuses the received initial electromagnetic field in the near-field region of the material structure.
    Type: Application
    Filed: May 20, 2021
    Publication date: June 29, 2023
    Inventors: Lutz Christian GERHARDT, Priscilla BRANDAO SILVA, Achim Rudolf HILGERS, Marco BARAGONA, Sergei Y. SHULEPOV
  • Patent number: 8465766
    Abstract: Aqueous wound and mucous membrane disinfectant containing a) octenidine dihydrochloride, and b) one or more active ingredients selected from the group ethanol, 1-propanol, 2-propanol, undecylene amidopropyl trimonium methosulfate, 3-(4-chlorophenoxy)-1,2-propanediol and/or sodium hydroxymethylglycinate and c) glycerin and/or 1,2-diols having 3 to 10 carbon atoms, and d) optionally surfactants, emulsifiers, solubilizers, pH regulators, dyestuffs, perfumes and/or thickeners, the agent being free of phenoxyethanol, phenoxypropanol, phenoxyisopropanol and organic acids.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: June 18, 2013
    Assignee: Bode Chemie GmbH
    Inventors: Barbara Krug, Sven Dabek, Kai-Martin Mueller, Marco Rudolf, Christiane Ostermeyer, Hiltraut Pietsch
  • Publication number: 20120208894
    Abstract: A multi-purpose hand disinfectant and in particular, a hand disinfectant which meets the FDA (Food and Drug Administration) requirements for use both as an antiseptic handwash or health-care personnel handwash drug product and as a surgical hand scrub drug product is described herein.
    Type: Application
    Filed: March 16, 2009
    Publication date: August 16, 2012
    Applicant: BODE Chemie GmbH & Co. KG
    Inventors: Guenter Kampf, Claudia James, Sven Eggerstedt, Marco Rudolf
  • Publication number: 20120070510
    Abstract: Aqueous wound and mucous membrane disinfectant containing a) octenidine dihydrochloride, and b) one or more active ingredients selected from the group ethanol, 1-propanol, 2-propanol, undecylene amidopropyl trimonium methosulfate, 3-(4-chlorophenoxy)-1,2-propanediol and/or sodium hydroxymethylglycinate and c) glycerin and/or 1,2-diols having 3 to 10 carbon atoms, and d) optionally surfactants, emulsifiers, solubilisers, pH regulators, dyestuffs, perfumes and/or thickeners, the agent being free of phenoxyethanol, phenoxypropanol, phenoxyisopropanol and organic acids.
    Type: Application
    Filed: September 20, 2011
    Publication date: March 22, 2012
    Inventors: BARBARA KRUG, Sven Dabek, Kai-Martin Mueller, Marco Rudolf, Hanns Pietsch, Hiltraut Pietsch, Christiane Ostermeyer
  • Publication number: 20090076084
    Abstract: Aqueous wound and mucous membrane disinfectant containing a) octenidine dihydrochloride, and b) one or more active ingredients selected from the group ethanol, 1-propanol, 2-propanol, undecylene amidopropyl trimonium methosulfate, 3-(4-chlorophenoxy)-1,2-propanediol and/or sodium hydroxymethylglycinate and c) glycerin and/or 1,2-diols having 3 to 10 carbon atoms, and d) optionally surfactants, emulsifiers, solubilisers, pH regulators, dyestuffs, perfumes and/or thickeners, the agent being free of phenoxyethanol, phenoxypropanol, phenoxyisopropanol and organic acids.
    Type: Application
    Filed: July 31, 2006
    Publication date: March 19, 2009
    Inventors: Barbara Krug, Sven Dabek, Kai-Martin Mueller, Marco Rudolf, Hanns Pietsch, Hiltraut Pietsch, Christiane Ostermeyer
  • Patent number: 5977078
    Abstract: The present invention provides compositions that are cell permeable antagonists of inositol polyphosphates. In addition, the invention provides methods for enhancing chloride ion secretion from a cell by contacting the cells with cell permeable antagonists of inositol polyphosphates. The invention also provides methods for enhancing chloride ion secretion in an individual by administering cell permeable antagonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with cystic fibrosis in an individual by administering a cell permeable antagonist of inositol polyphosphates to the individual. The invention also provides compositions that are cell permeable agonists of inositol polyphosphates. In addition, the invention provides methods for decreasing chloride ion secretion from a cell by contacting the cell with cell permeable agonists of inositol polyphosphates.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: November 2, 1999
    Assignee: The Regents of the Univesity of California
    Inventors: Alexis Traynor-Kaplan, Carsten Schultz, Stefan Roemer, Christoph Stadler, Marco Rudolf
  • Patent number: 5880099
    Abstract: The present invention provides compositions that are cell permeable antagonists of inositol polyphosphates. In addition, the invention provides methods for enhancing chloride ion secretion from a cell by contacting the cells with cell permeable antagonists of inositol polyphosphates. The invention also provides methods for enhancing chloride ion secretion in an individual by administering cell permeable antagonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with cystic fibrosis in an individual by administering a cell permeable antagonist of inositol polyphosphates to the individual. The invention also provides compositions that are cell permeable agonists of inositol polyphosphates. In addition, the invention provides methods for decreasing chloride ion secretion from a cell by contacting the cell with cell permeable agonists of inositol polyphosphates.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: March 9, 1999
    Assignee: The Regents of the University of California
    Inventors: Alexis Traynor-Kaplan, Carsten Schultz, Stefan Roemer, Christoph Stadler, Marco Rudolf